BR112015015493A2 - composição farmacêutica que contém um derivado de n-fenilpirazol e de permetrina, uso para a preparação de um medicamento veterinário tópico - Google Patents

composição farmacêutica que contém um derivado de n-fenilpirazol e de permetrina, uso para a preparação de um medicamento veterinário tópico

Info

Publication number
BR112015015493A2
BR112015015493A2 BR112015015493A BR112015015493A BR112015015493A2 BR 112015015493 A2 BR112015015493 A2 BR 112015015493A2 BR 112015015493 A BR112015015493 A BR 112015015493A BR 112015015493 A BR112015015493 A BR 112015015493A BR 112015015493 A2 BR112015015493 A2 BR 112015015493A2
Authority
BR
Brazil
Prior art keywords
phenylpyrazole
permethrin
pharmaceutical composition
derivative
preparation
Prior art date
Application number
BR112015015493A
Other languages
English (en)
Other versions
BR112015015493A8 (pt
BR112015015493B1 (pt
Inventor
Havrileck Bertrand
Delhom Nathalie
Original Assignee
Virbac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virbac filed Critical Virbac
Publication of BR112015015493A2 publication Critical patent/BR112015015493A2/pt
Publication of BR112015015493A8 publication Critical patent/BR112015015493A8/pt
Publication of BR112015015493B1 publication Critical patent/BR112015015493B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

resumo “composição farmacêutica que contém um derivado de n-fenilpirazol e de permetrina, uso para a preparação de um medicamento veterinário tópico” a presente invenção trata de uma composição farmacêutica veterinária tópica constituída de um n-fenilpirazol, de permetrina e de um inibidor de mudança de fase escolhido entre o etanol, o álcool benzílico e sua mistura; de seu uso na prevenção e/ou no tratamento das infestações des animais domésticos por parasitas externos.
BR112015015493-0A 2012-12-27 2013-12-20 Composição farmaceutica veterinaria e uso de uma composicao farmaceutica veterinaria BR112015015493B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1262822A FR3000393B1 (fr) 2012-12-27 2012-12-27 Association topique d'un n-phenylpyrazole et de permethrine
FR1262822 2012-12-27
PCT/IB2013/061218 WO2014102693A1 (fr) 2012-12-27 2013-12-20 Composition pharmaceutique contenant un derive de n-phenylpyrazole et de permethrine, utilisation pour la preparation d'un medicament veterinaire topique

Publications (3)

Publication Number Publication Date
BR112015015493A2 true BR112015015493A2 (pt) 2017-07-11
BR112015015493A8 BR112015015493A8 (pt) 2019-10-22
BR112015015493B1 BR112015015493B1 (pt) 2020-11-24

Family

ID=48224910

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015015493-0A BR112015015493B1 (pt) 2012-12-27 2013-12-20 Composição farmaceutica veterinaria e uso de uma composicao farmaceutica veterinaria

Country Status (5)

Country Link
EP (1) EP2938361A1 (pt)
AU (1) AU2013368970A1 (pt)
BR (1) BR112015015493B1 (pt)
FR (1) FR3000393B1 (pt)
WO (1) WO2014102693A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9392792B1 (en) * 2014-12-30 2016-07-19 Virbac Topical combination of fipronil, permethrin and pyriproxyfen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8713768D0 (en) 1987-06-12 1987-07-15 May & Baker Ltd Compositions of matter
GB8816915D0 (en) 1988-07-15 1988-08-17 May & Baker Ltd New compositions of matter
FR2739255B1 (fr) * 1995-09-29 1998-09-04 Rhone Merieux Composition antiparasitaire pour le traitement et la protection des animaux de compagnie
US6660768B2 (en) * 2001-02-08 2003-12-09 Schering-Plough Animal Health Corporation Parasiticidal compositions and methods of use
DE102006061538A1 (de) 2006-12-27 2008-07-03 Bayer Healthcare Ag Kombinationsprodukt zur Bekämpfung von Parasiten an Tieren
US9433615B2 (en) 2007-09-06 2016-09-06 The Hartz Mountain Corporation Animal parasite-control method using insect growth regulators
EP2375905B1 (fr) * 2008-12-16 2012-12-05 Virbac Composition pharmaceutique contenant un derive de n-phenylpyrazole, utilisation pour la preparation d'un medicament veterinaire topique pour lutter contre les puces
JP5736376B2 (ja) 2009-09-22 2015-06-17 サージェンツ ペット ケア プロダクツ アイエヌシー． 局所殺虫性組成物

Also Published As

Publication number Publication date
BR112015015493A8 (pt) 2019-10-22
FR3000393B1 (fr) 2015-01-16
WO2014102693A1 (fr) 2014-07-03
BR112015015493B1 (pt) 2020-11-24
FR3000393A1 (fr) 2014-07-04
EP2938361A1 (fr) 2015-11-04
AU2013368970A1 (en) 2015-07-16

Similar Documents

Publication Publication Date Title
BR112015014372A8 (pt) inibidores de autotaxina, seus usos, e composição e combinação farmacêuticas".
BRPI0924460A2 (pt) composição farmacêutica para uso em oftalmologia médica e veterinária
CA2894891A1 (en) Boronic acid derivatives and therapeutic uses thereof
BR112015000150A2 (pt) composições farmacêuticas dissuasoras de abuso de liberação controlada
GT201000160A (es) Derivados de aminobenzamida como agentes útiles para el control de parásitos de animales
GT200600445A (es) Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo.
BR112015008487A2 (pt) compostos de benzeno substituído
BRPI0507755A (pt) composto de pirazolina substituìda, processo para a sua manufatura, medicamentos e seus usos
BR112013017779A2 (pt) derivados de oxazina e seu uso no tratamento de distúrbios neurológicos
BRPI0507790A (pt) composto de pirazolina substituìda, processo para a sua manufatura, medicamentos e seus usos
BR112014022214A2 (pt) fenólicos antibacterianos
WO2015038533A3 (en) Sodium channel modulators for the treatment of pain and diabetes
BR112014015630A2 (pt) fluorometil-5,6-di-hidro-4h-[1,3]oxazinas
BR112015019412A2 (pt) inibidores de bace1
BR112012023431A2 (pt) dispositivo de distribuição de fármacos
CL2008001820A1 (es) Compuestos derivados de aril-isoxasol-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y uso en la preparacion de medicamentos utiles en el tratamiento de trastornos cognitivos y enfermedades relacionadas con alzheimer.
PT103884A (pt) Composições de libertação prolongada e métodos para a sua preparação
BR112013028895A2 (pt) (tio)carbonilamidinas bicíclicas
BR112015001207A8 (pt) derivados de carbamato/ureia, seus usos, composição farmacêutica, forma livre e seu método de preparação
BR112017001093A2 (pt) formulação aquosa compreendendo paracetamol e ibuprofeno
BR112016027383A8 (pt) derivados de naftiridinadiona, seus usos, composição farmacêutica e combinação
AR095032A1 (es) Formulaciones de compuestos orgánicos, composición farmacéutica sólida comprimida por rodillo
BR112015015250A2 (pt) derivados de pirrolidina, composições farmacêuticas e usos dos mesmos
BR112015029073A8 (pt) tinturas dispersas, seu uso e seu processo de produção, e processo para tingimento e impressão de materiais hidrofóbicos
BR112015015493A2 (pt) composição farmacêutica que contém um derivado de n-fenilpirazol e de permetrina, uso para a preparação de um medicamento veterinário tópico

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/12/2013, OBSERVADAS AS CONDICOES LEGAIS.